Published Study Demonstrates Natera's Ability to Identify Heterogeneous Cancer Mutations in Patients with Early-Stage Lung Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. PRIM
3. MU
4. DPZ
5. ACN
6. NAVN
7. DFTX
8. IBM
9. META
10. ENRD

Go back to Published Study Demonstrates Natera's Ability to Identify Heterogeneous Cancer Mutations in Patients with Early-Stage Lung Cancer
(NASDAQ: NTRA) Delayed: 228.80 --0 (-0%)
Previous Close $228.80    52 Week High $13.80 
Open $228.80    52 Week Low $6.52 
Day High $228.80    P/E N/A 
Day Low $228.80    EPS $0.00 
Volume 985